Cargando…
Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries
IMPORTANCE: Direct-acting antiviral (DAA) therapy for hepatitis C is highly effective but expensive. Evidence is scarce on whether DAA therapy reduces downstream medical costs. OBJECTIVE: To examine the association of DAA therapy with posttreatment medical costs among Medicare beneficiaries. DESIGN,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327546/ https://www.ncbi.nlm.nih.gov/pubmed/32602909 http://dx.doi.org/10.1001/jamanetworkopen.2020.8081 |